-
1
-
-
0026603916
-
Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset
-
Carey, G.J., Costall, B., Domeney, A.M. et al. Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol Biochem Behav 1992, 42: 75-83.
-
(1992)
Pharmacol Biochem Behav
, vol.42
, pp. 75-83
-
-
Carey, G.J.1
Costall, B.2
Domeney, A.M.3
-
2
-
-
0029121484
-
Ondansetron improves cognitive performance in the Morris water maze spatial navigation task
-
Fontana, D.J., Daniels, S.E., Henderson, C., Eglen, R.M., Wong, E.H.F. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology 1995, 120: 409-17.
-
(1995)
Psychopharmacology
, vol.120
, pp. 409-417
-
-
Fontana, D.J.1
Daniels, S.E.2
Henderson, C.3
Eglen, R.M.4
Wong, E.H.F.5
-
3
-
-
0027176587
-
3 receptor antagonist, selectively antagonises scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotlity in rats
-
3 receptor antagonist, selectively antagonises scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotlity in rats. J Pharm Pharmacol 1993, 45: 841-3.
-
(1993)
J Pharm Pharmacol
, vol.45
, pp. 841-843
-
-
Brambilla, A.1
Ghiorzi, A.2
Pitsikas, N.3
Borsini, F.4
-
4
-
-
0343800219
-
3 receptor antagonist, GR 68755, prevents a scopolamine-induced cognitive impairment in the common marmoset
-
3 receptor antagonist, GR 68755, prevents a scopolamine-induced cognitive impairment in the common marmoset. Br J Pharmacol 1990, 100 (Suppl.): 309P.
-
(1990)
Br J Pharmacol
, vol.100
, Issue.SUPPL.
-
-
Jones, D.N.C.1
Carey, G.J.2
Costall, B.3
-
7
-
-
0026056887
-
The effect of ondansetron on cognitive performance in the marmoset
-
Domeney, A.M., Costall, B., Gerrard, P.A., Jones, D.N.C., Naylor, R.J., Tyers, M.B. The effect of ondansetron on cognitive performance in the marmoset. Pharmacol Biochem Behav 1991, 38: 169-75.
-
(1991)
Pharmacol Biochem Behav
, vol.38
, pp. 169-175
-
-
Domeney, A.M.1
Costall, B.2
Gerrard, P.A.3
Jones, D.N.C.4
Naylor, R.J.5
Tyers, M.B.6
-
9
-
-
0025309366
-
Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice
-
Sharma, A.C., Kulkarni, S.K. Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice. Meth Find Exp Clin Pharmacol 1990, 12(3): 175-80.
-
(1990)
Meth Find Exp Clin Pharmacol
, vol.12
, Issue.3
, pp. 175-180
-
-
Sharma, A.C.1
Kulkarni, S.K.2
-
10
-
-
0003145718
-
Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity
-
Martin, J.R., Haefely, W.E. Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity. Drug Invest 1993, 5 (Suppl. 1): 4-49.
-
(1993)
Drug Invest
, vol.5
, Issue.1 SUPPL.
, pp. 4-49
-
-
Martin, J.R.1
Haefely, W.E.2
-
11
-
-
0027787456
-
2 dopamine receptor participation in learning and memory in mice
-
2 dopamine receptor participation in learning and memory in mice. Meth Find Exp Clin Pharmacol 1993, 15(9): 597-607.
-
(1993)
Meth Find Exp Clin Pharmacol
, vol.15
, Issue.9
, pp. 597-607
-
-
Verma, A.1
Kulkarni, S.K.2
-
12
-
-
8244253653
-
Pharmacological profile of BR-16A (MENTAT®)
-
Kulkarni, S.K., Verma, A. Pharmacological profile of BR-16A (MENTAT®). Probe 1995, 124-34.
-
(1995)
Probe
, pp. 124-134
-
-
Kulkarni, S.K.1
Verma, A.2
|